eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2010
vol. 5
 
Share:
Share:
more
 
 
abstract:
Case report

Evaluation of the treatment efficacy with adalimumab in Crohn’s disease – case report

Piotr Eder
,
Liliana Łykowska-Szuber
,
Iwona Krela-Kazimierczak
,
Katarzyna Iwanik
,
Katarzyna Karmelita-Katulska
,
Przemysław Majewski
,
Krzysztof Linke

Przegląd Gastroenterologiczny 2010; 5 (1): 47–51
Online publish date: 2010/05/07
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Usage of anti-TNF-α agents in Crohn’s disease is one of the most important therapeutic achievements in Gastro-enterology over the last few years. Unfortunately there is still a lack of evidence on how to assess objectively the performance of this biological therapy. In this paper we present a case study of a patient treated with adalimumab, in which we assessed the efficacy of the treatment relying not only on the clinical indices and laboratory markers, but also on endoscopic, histological, and radiological methods.
keywords:

Crohn’s disease, adalimumab, mucosal healing

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe